CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Transition adjustment related to adoption of ASC326, net of tax	Common Stock	Accumulated Deficit	Accumulated Deficit Transition adjustment related to adoption of ASC326, net of tax	Accumulated Other Comprehensive (Loss) Income
Balance (in shares) at Dec. 31, 2020			3,943,572
Balance at Dec. 31, 2020	$ 63,219		$ 106,329	$ (42,592)		$ (518)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	5,094			5,094
Unrealized holding loss on available-for-sale securities, net of tax	(1,119)					(1,119)
Comprehensive (loss) income	3,975			5,094		(1,119)
Share-based compensation expense	150		$ 150
Vesting of restricted stock (in shares)			12,920
Balance (in shares) at Dec. 31, 2021			3,956,492
Balance at Dec. 31, 2021	67,344		$ 106,479	(37,498)		(1,637)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	6,161			6,161
Unrealized holding loss on available-for-sale securities, net of tax	(14,008)					(14,008)
Comprehensive (loss) income	(7,847)			6,161		(14,008)
Share-based compensation expense	$ 86		$ 86
Vesting of restricted stock (in shares)			8,694
Balance (in shares) at Dec. 31, 2022	3,965,186		3,965,186
Balance at Dec. 31, 2022	$ 59,583	$ (11,510)	$ 106,565	(31,337)	$ (11,510)	(15,645)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(4,179)			(4,179)
Unrealized holding loss on available-for-sale securities, net of tax	384					384
Comprehensive (loss) income	(3,795)			(4,179)		384
Share-based compensation expense	$ 105		$ 105
Vesting of restricted stock (in shares)			10,887
Balance (in shares) at Dec. 31, 2023	3,976,073		3,976,073
Balance at Dec. 31, 2023	$ 44,383		$ 106,670	$ (47,026)		$ (15,261)